← Leaderboards

Guido Silvestri

Emory University

Google Scholar ↗PubMed ↗ORCID ↗

$61,186,493

Attributed

$80,401,557

Total exposure

41

Grants

36

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $8.5M · FY2005–25

$10M$7.5M$5M$2.5M$0

'05

'06

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$80,401,557 · 41

By mechanism

UM1$25,334,968 · 1

R01$18,210,126 · 5

P01$15,622,765 · 4

R37$7,712,145 · 1

P30$5,574,030 · 2

R24$3,202,408 · 1

Top collaborators

Most similar at Emory University

Same institution · by research overlap

Francois J Villinger$61,853,654
Siddappa N Byrareddy$14,019,085
Rama Rao Amara$90,840,294
Mark B. Feinberg$16,950,022
Harriet L Robinson$13,479,393

Others in their field

Top investigators on “Infection”

Wafaa M. El-Sadr · Columbia University Health Sciences$965,939,185
Lawrence Corey · Fred Hutchinson Cancer Center$789,608,171
Judith S. Currier · University Of California Los Angeles$511,038,212
Margaret Juliana McElrath · Fred Hutchinson Cancer Center$463,711,983
Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
Joseph J. Eron · Univ Of North Carolina Chapel Hill$415,229,497

Research focus

InfectionMacaca MulattaAnimalsCellsVirusIn VivoHiv InfectionsBaseAcquired Immunodeficiency SyndromeImmunePrimatesCd4 Positive T LymphocytesResourcesVirus ReplicationAntiretroviral TherapyPathogenesisResearch PersonnelResponseViralCercocebus AtysSourceResearch StudyImmune ResponseMediating

Grant awards (110)

Enterprise for Research and Advocacy to Stop and Eradicate HIV (ERASE-HIV)$4,663,729

UM1 · FY2025 · AI

Antiviral role of CD8+T cells in ART-treated SIV-infected macaques$882,697

R01 · FY2025 · AI · contact PI

Core J: Virology and Molecular Biomarkers$321,420

P30 · FY2025 · AI · contact PI

Enterprise for Research and Advocacy to Stop and Eradicate HIV (ERASE-HIV)$4,667,081

UM1 · FY2024 · AI

Antiviral role of CD8+T cells in ART-treated SIV-infected macaques$909,998

R01 · FY2024 · AI · contact PI

Core J: Virology and Molecular Biomarkers$484,348

P30 · FY2024 · AI · contact PI

Enterprise for Research and Advocacy to Stop and Eradicate HIV (ERASE-HIV)$5,636,888

UM1 · FY2023 · AI

Antiviral role of CD8+T cells in ART-treated SIV-infected macaques$909,998

R01 · FY2023 · AI · contact PI

Core J: Virology and Molecular Biomarkers$503,716

P30 · FY2023 · AI · contact PI

Enterprise for Research and Advocacy to Stop and Eradicate HIV (ERASE-HIV)$5,412,341

UM1 · FY2022 · AI

Core J: Virology and Molecular Biomarkers$1,136,053

P30 · FY2022 · AI · contact PI

Core B_Silvestri$1,060,779

P01 · FY2022 · AI · contact PI

Antiviral role of CD8+T cells in ART-treated SIV-infected macaques$909,998

R01 · FY2022 · AI · contact PI

Enterprise for Research and Advocacy to Stop and Eradicate HIV (ERASE-HIV)$4,954,929

UM1 · FY2021 · AI

Antiviral role of CD8+T cells in ART-treated SIV-infected macaques$909,998

R01 · FY2021 · AI · contact PI

Core B_Silvestri$754,534

P01 · FY2021 · AI · contact PI

Core J: Virology and Molecular Biomarkers Core$432,284

P30 · FY2021 · AI · contact PI

Core 1: Non-human primate core$422,869

P01 · FY2021 · AI · contact PI

Antiviral role of CD8+ T cells in ART-treated SIV-infected macaques$837,286

R01 · FY2020 · AI · contact PI

STUDIES OF NATURAL SIV INFECTION OF SOOTY MANGABEYS$824,192

R37 · FY2020 · AI · contact PI

Core J: Virology and Molecular Biomarkers Core$782,351

P30 · FY2020 · AI · contact PI

Core 1: Non-human primate core$400,441

P01 · FY2020 · AI · contact PI

Core 1: Non-human primate core$113,131

P01 · FY2020 · AI · contact PI

Project 3- Mucosal Determinants of Virus Transmission$1,824,620

P01 · FY2019 · AI · contact PI

STUDIES OF NATURAL SIV INFECTION OF SOOTY MANGABEYS$837,597

R37 · FY2019 · AI · contact PI

Antiviral role of CD8+ T cells in ART-treated SIV-infected macaques$835,203

R01 · FY2019 · AI · contact PI

Core J: Virology and Molecular Biomarkers Core$813,884

P30 · FY2019 · AI · contact PI

Core 1: Non-human primate core$665,255

P01 · FY2019 · AI · contact PI

Project 3- Mucosal Determinants of Virus Transmission$1,881,335

P01 · FY2018 · AI · contact PI

STUDIES OF NATURAL SIV INFECTION OF SOOTY MANGABEYS$851,495

R37 · FY2018 · AI · contact PI

Antiviral role of CD8+ T cells in ART-treated SIV-infected macaques$812,443

R01 · FY2018 · AI · contact PI

Core 1: Non-human primate core$808,571

P01 · FY2018 · AI · contact PI

Core J: Virology and Molecular Biomarkers Core$663,750

P30 · FY2018 · AI · contact PI

Project 3- Mucosal Determinants of Virus Transmission$2,974,489

P01 · FY2017 · AI · contact PI

Antiviral role of CD8+ T cells in ART-treated SIV-infected macaques$875,289

R01 · FY2017 · AI · contact PI

STUDIES OF NATURAL SIV INFECTION OF SOOTY MANGABEYS$842,815

R37 · FY2017 · AI · contact PI

Core 1: Non-human primate core$496,498

P01 · FY2017 · AI · contact PI

Core J: Virology and Molecular Biomarkers Core$436,224

P30 · FY2017 · AI · contact PI

STUDIES OF NATURAL SIV INFECTION OF SOOTY MANGABEYS$813,556

R37 · FY2016 · AI · contact PI

Transcriptome resources for comparative primate models of lentivirus infection$804,011

R24 · FY2016 · OD · contact PI

Antiviral role of CD8+ T cells in ART-treated SIV-infected macaques$800,953

R01 · FY2016 · AI · contact PI

Project 3- Mucosal Determinants of Virus Transmission$602,164

P01 · FY2016 · AI · contact PI

Transcriptome resources for comparative primate models of lentivirus infection$789,409

R24 · FY2015 · OD · contact PI

STUDIES OF NATURAL SIV INFECTION OF SOOTY MANGABEYS$715,465

R37 · FY2015 · AI · contact PI

Targeting SIV reservoirs with type I Interferons$234,936

R21 · FY2015 · AI · contact PI

Transcriptome resources for comparative primate models of lentivirus infection$740,376

R24 · FY2014 · OD · contact PI

STUDIES OF NATURAL SIV INFECTION OF SOOTY MANGABEYS$715,465

R37 · FY2014 · AI · contact PI

Targeting SIV reservoirs with type I Interferons$255,794

R21 · FY2014 · AI · contact PI

Persistent Virus Reservoirs in SIV-infected Macaques$221,247

R21 · FY2014 · AI

Transcriptome resources for comparative primate models of lentivirus infection$868,612

R24 · FY2013 · OD · contact PI

Mechanisms of SIV suppression by CD8+ lymphocytes$733,243

R01 · FY2013 · AI · contact PI

STUDIES OF NATURAL SIV INFECTION OF SOOTY MANGABEYS$683,273

R37 · FY2013 · AI · contact PI

Persistent Virus Reservoirs in SIV-infected Macaques$267,750

R21 · FY2013 · AI

Mechanisms of SIV suppression by CD8+ lymphocytes$795,676

R01 · FY2012 · AI · contact PI

STUDIES OF NATURAL SIV INFECTION OF SOOTY MANGABEYS$703,587

R37 · FY2012 · AI · contact PI

Immune Activation and AIDS Pathogenesis in SIV-Infected Non-Human Primates$652,495

P01 · FY2012 · AI · contact PI

Mechanisms of SIV suppression by CD8+ lymphocytes$814,996

R01 · FY2011 · AI · contact PI

Immune Activation and AIDS Pathogenesis in SIV-Infected Non-Human Primates$792,774

P01 · FY2011 · AI · contact PI

STUDIES OF NATURAL SIV INFECTION OF SOOTY MANGABEYS$724,700

R37 · FY2011 · AI · contact PI

STUDIES OF NATURAL SIV-INFECTION IN SOOTY MANGABEYS$89,196

P51 · FY2011 · RR · contact PI

IMMUNE ACTIVATION AND AIDS PATHOGENESIS IN SIV-INFECTED NON-HUMAN PRIMATES$74,294

P51 · FY2011 · RR · contact PI

PRE-CLINICAL IMMUNOGENICITY STUDIES OF CHIMPANZEE ADENOVIRUS VECTORS$74,294

P51 · FY2011 · RR · contact PI

IMMUNO-VIROLOGICAL AND SAMPLE REPOSITORY SIV-INFECTED AND UNINFECTED MANGABEYS$74,294

P51 · FY2011 · RR · contact PI

MUCOSAL T CELL RESPONSES AND PROTECTION FROM SIMIAN AIDS$74,294

P51 · FY2011 · RR · contact PI

MECHANISMS OF SIV SUPPRESSION BY CD8+ LYMPHOCYTES$74,294

P51 · FY2011 · RR · contact PI

Mechanisms of SIV suppression by CD8+ lymphocytes$842,716

R01 · FY2010 · AI · contact PI

Immune Activation and AIDS Pathogenesis in SIV-Infected Non-Human Primates$766,440

P01 · FY2010 · AI · contact PI

Studies of Natural SIV Infection of Sooty Mangabeys$357,984

R01 · FY2010 · AI · contact PI

Studies of Natural SIV Infection of Sooty Mangabeys$304,212

R01 · FY2010 · AI · contact PI

HOST SPECIFIC RESPONSES IN SIV-INDUCED HEMATOSUPPRESSION$65,793

P51 · FY2010 · RR · contact PI

STUDIES OF NATURAL SIV-INFECTION IN SOOTY MANGABEYS$65,793

P51 · FY2010 · RR · contact PI

IMMUNE ACTIVATION AND AIDS PATHOGENESIS IN SIV-INFECTED NON-HUMAN PRIMATES$54,827

P51 · FY2010 · RR · contact PI

PRE-CLINICAL IMMUNOGENICITY STUDIES OF CHIMPANZEE ADENOVIRUS VECTORS$54,827

P51 · FY2010 · RR · contact PI

Studies of Natural SIV Infection of Sooty Mangabeys$1,084,275

R01 · FY2009 · AI · contact PI

Immune Activation and AIDS Pathogenesis in SIV-Infected Non-Human Primates$786,931

P01 · FY2009 · AI · contact PI

STUDIES OF NATURAL SIV-INFECTION IN SOOTY MANGABEYS$68,028

P51 · FY2009 · RR · contact PI

HOST SPECIFIC RESPONSES IN SIV-INDUCED HEMATOSUPPRESSION$68,028

P51 · FY2009 · RR · contact PI

Immune Activation and AIDS Pathogenesis in SIV-Infected Non-Human Primates$619,439

P01 · FY2008 · AI · contact PI

Studies of Natural SIV Infection of Sooty Mangabeys$569,765

R01 · FY2008 · AI · contact PI

Determinants of Vaccine-Induced Memory T Cell Development$198,480

U19 · FY2008 · AI · contact PI

STUDIES OF NATURAL SIV-INFECTION IN SOOTY MANGABEYS$81,625

P51 · FY2008 · RR · contact PI

ENHANCING THE IMMUNOGENICITY OF MVA-BASED AIDS VACCINES$81,625

P51 · FY2008 · RR · contact PI

HOST SPECIFIC RESPONSES IN SIV-INDUCED HEMATOSUPPRESSION$81,625

P51 · FY2008 · RR · contact PI

STUDIES OF THE HIV ASSOCIATED CELL CYCLE DISEASE$81,625

P51 · FY2008 · RR · contact PI

Studies of Natural SIV Infection of Sooty Mangabeys$25,277

R01 · FY2008 · AI · contact PI

Host specific responses in SIV-induced hematosuppression$610,037

R01 · FY2007 · HL · contact PI

Studies of Natural SIV Infection of Sooty Mangabeys$588,579

R01 · FY2007 · AI · contact PI

Determinants of Vaccine-Induced Memory T Cell Development$316,975

U19 · FY2007 · AI · contact PI

HOMEOSTASIS OF T CELLS IN PRIMATES$78,544

P51 · FY2007 · RR · contact PI

STUDIES OF THE HIV ASSOCIATED CELL CYCLE DISEASE$65,453

P51 · FY2007 · RR · contact PI

IMMUNO-VIROLOGICAL AND SAMPLE REPOSITORY SIV-INFECTED AND UNINFECTED MANGABEYS$52,365

P51 · FY2007 · RR · contact PI

Studies of Natural SIV Infection of Sooty Mangabeys$611,141

R01 · FY2006 · AI · contact PI

Host specific responses in SIV-induced hematosuppression$610,748

R01 · FY2006 · HL · contact PI

Studies of the HIV-associated cell cycle disease$383,276

R01 · FY2006 · AI · contact PI

Determinants of Vaccine-Induced Memory T Cell Development$340,362

U19 · FY2006 · AI · contact PI

STUDIES OF THE HIV ASSOCIATED CELL CYCLE DISEASE$59,665

P51 · FY2006 · RR · contact PI

HOMEOSTASIS OF T CELLS IN PRIMATES$59,665

P51 · FY2006 · RR · contact PI

Determinants of Vaccine-Induced Memory T Cell Development$416,254

U19 · FY2005 · AI

Studies of the HIV-associated cell cycle disease$296,338

R01 · FY2005 · AI

Studies of the HIV-associated cell cycle disease$98,000

R01 · FY2005 · AI

HOMEOSTASIS OF T CELLS IN PRIMATES$52,438

P51 · FY2005 · RR

STUDIES OF THE HIV ASSOCIATED CELL CYCLE DISEASE$52,438

P51 · FY2005 · RR

Determinants of Vaccine-Induced Memory T Cell Development$409,435

U19 · FY2004 · AI

Studies of the HIV-associated cell cycle disease$400,000

R01 · FY2004 · AI

STUDIES OF THE HIV ASSOCIATED CELL CYCLE DISEASE$51,707

P51 · FY2004 · RR

HOMEOSTASIS OF T CELLS IN PRIMATES$51,707

P51 · FY2004 · RR

STUDIES OF HOMEOSTATIC PROLIFERATION OF T-CELLS$34,361

P51 · FY2004 · RR

Studies of the HIV-associated cell cycle disease$400,000

R01 · FY2003 · AI

Homeostasis of T cells in primates$331,100

R21 · FY2003 · AI

STUDIES OF HOMEOSTATIC PROLIFERATION OF T-CELLS IN PRIMATES$29,977

P51 · FY2003 · RR